WallStreetZenWallStreetZen

NASDAQ: ARQT
Arcutis Biotherapeutics Inc Stock Ownership - Who owns Arcutis Biotherapeutics?

Insider buying vs selling

Have Arcutis Biotherapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Patrick BurnettReporting Persons title Senior Vice President and Chief Medical Officer2024-05-029,555$8.74
$83.49kSell
Masaru MatsudaReporting Persons title Senior Vice President and General Counsel2024-05-025,016$8.74
$43.83kSell
Todd Franklin WatanabeReporting Persons title President and Chief Executive Officer2024-05-0213,783$8.74
$120.44kSell
Matthew Richard MooreSVP and Chief Business Officer2024-05-024,681$8.74
$40.90kSell
Patrick J. HeronDirector2024-03-0421,052$9.50
$199.99kBuy
Patrick BurnettReporting Persons title Senior Vice President Chief Medical Officer2024-03-044,782$11.12
$53.18kSell
Todd Franklin WatanabeReporting Persons title President and Chief Executive Officer2024-03-0414,903$11.12
$165.74kSell
Matthew Richard MooreSVP and Chief Business Officer2024-03-043,468$11.12
$38.57kSell
Masaru MatsudaReporting Persons title Senior Vice President and General Counsel2024-03-043,760$11.12
$41.81kSell
Todd Franklin WatanabeReporting Persons title President and Chief Executive Officer2024-02-282,465$10.60
$26.13kSell

1 of 2

ARQT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ARQT insiders and whales buy or sell their stock.

ARQT Shareholders

What type of owners hold Arcutis Biotherapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Patrick J. Heron16.72%19,360,456$176.57MInsider
Jennison Associates LLC10.52%12,176,315$111.05MInstitution
Frazier Life Sciences Viii LP7.63%8,838,534$80.61MInsider
Frazier Life Sciences Management LP7.59%8,785,284$80.12MInstitution
State Street Corp7.59%8,784,038$80.11MInstitution
Suvretta Capital Management LLC6.80%7,877,297$71.84MInstitution
Rubric Capital Management LP6.49%7,510,000$68.49MInstitution
Polar Capital Holdings PLC5.95%6,885,922$62.80MInstitution
Blackrock Inc5.75%6,658,741$60.73MInstitution
Vanguard Group Inc4.46%5,166,417$47.12MInstitution

1 of 3

ARQT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARQT77.06%22.94%Net BuyingNet Selling
ABCL40.83%47.34%Net BuyingNet Buying
VRNA10.26%55.71%Net SellingNet Selling
ELVN49.49%50.51%Net SellingNet Selling
PHVS78.83%0.00%

Arcutis Biotherapeutics Stock Ownership FAQ

Who owns Arcutis Biotherapeutics?

Arcutis Biotherapeutics (NASDAQ: ARQT) is owned by 107.80% institutional shareholders, 32.08% Arcutis Biotherapeutics insiders, and 0.00% retail investors. Patrick J. Heron is the largest individual Arcutis Biotherapeutics shareholder, owning 19.36M shares representing 16.72% of the company. Patrick J. Heron's Arcutis Biotherapeutics shares are currently valued at $178.12M.

If you're new to stock investing, here's how to buy Arcutis Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.